Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2015-03-31
2019-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Onset Time of Nerve Block: A Comparison of Two Injection Locations in Patients Having Lower Leg/ Foot Surgery
NCT01542840
Ultrasound-Guided Continuous Sciatic Nerve Blocks: Popliteal Versus Subgluteal Catheters
NCT01325012
Circumferential Spread of Anesthetic and Success in Sciatic Nerve Blockade
NCT00802581
Perineural Local Anesthetic Administration With a Continuous Infusion Versus Automatic Intermittent Boluses
NCT04458467
Ultrasound Guided Popliteal Fossa Block. Does Blockade Distal to Sciatic Nerve Bifurcation Speed Onset Time? A Prospective, Randomized Trial
NCT00803426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Leg in a neutral position
Sciatic nerve block, with leg kept in a neutral position after anesthesia (control group)
Sciatic Nerve block
Leg in a neutral position
Leg raised 30°
Sciatic nerve block, with leg raised 30° by placing the back of the foot over a support placed on the OR table and maintained in that position for 15 min
Sciatic Nerve block
Leg raised 30°
Distal tourniquet placed on the lower part of the leg
Sciatic nerve block, and distal tourniquet placed on the lower part of the leg (upper part of the tourniquet being about 4-6 inches from the ankle) with the leg in a neutral position.
Sciatic Nerve block
Distal tourniquet placed on the lower part of the leg
Leg in a neutral position
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sciatic Nerve block
Leg raised 30°
Distal tourniquet placed on the lower part of the leg
Leg in a neutral position
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologist physical status 1-3, meaning patients who are either completely or their systemic disease(s), if they have is (are) under control with medications or other means.
* Have capacity to provide informed consent.
Exclusion Criteria
* infection at injection site
* allergy to local anesthetics
* severe cardiopulmonary disease (heart and lung disease)
* body mass index \>35 kg.m2
* known neuropathies (degenerative, infectious and traumatic peripheral nerve diseases)
* who are receiving opioids for chronic analgesic therapy at the time of contemplated surgery
* Patients with history of AIDS, tuberculosis, and other infections
* active and/or unstable cardiac, renal, pulmonary and neurologic disorders will be excluded from the study. This includes patients in heart failure having limited exercise ability, end stage renal failure on dialysis treatment, recent stroke etc.
* Vulnerable subjects (children, pregnant subjects, prisoners, mentally impaired) also will not be included in the study.
* Subjects who do not understand or speak English
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Levon Capan, MD
Role: PRINCIPAL_INVESTIGATOR
New York University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-01327
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.